Prohance

Product manufactured by Bracco Diagnostics Inc

Application Nr Approved Date Route Status External Links
NDA020131 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Central Nervous System Prohance (Gadoteridol) Injection Is Indicated For Use In Mri In Adults And Children Over 2 Years Of Age To Visualize Lesions With Abnormal Vascularity In The Brain (Intracranial Lesions), Spine And Associated Tissues. Extracranial/extraspinal Tissues Prohance Is Indicated For Use In Mri In Adults To Visualize Lesions In The Head And Neck.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Gadoteridol GADOTERIDOL ZINC22016981

Comments